BioWorld MedTech

Sep. 3, 2010

Spine market facing growth challenges, analyst says

Right now it's better to be a smaller, well-capitalized spine company with a broad product line than a larger spine company, according to one analyst who covers the space. (Medical Device Daily) Read More

Study shows Cepheid's test is an 'Xpert' in diagnosing TB

SYNTAX creates common ground for coronary risk assessment

Washington roundup: Alphatec warned after taking back some manufacturing work

Holiday notice

Med-Tech Notes

Deals roundup: Erba buys most of Ivax shares for $15M

MDD's food for med-tech thought

Agreements/contracts: LifeCell to distribute Novadaq's SPY imaging

Courts report: Allergan to pay $600M to settle Botox-related charges

Financings roundup: AHP discloses results of self-tender offer

Restructuring roundup: Angeion restructures board and names two new officers

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...